Unexplained weight loss, or losing weight without trying, can be a perplexing clinical presentation for physicians. It may be an indicator of various underlying health conditions, some of which can be serious. This article aims to provide a comprehensive approach to the evaluation and management of unexplained weight loss.
The evaluation of unexplained weight loss should begin with a detailed history and physical examination. The history should focus on the amount and duration of weight loss, dietary intake, physical activity, and associated symptoms. The physical examination should be comprehensive, with particular attention to signs of systemic disease.
Common causes of unexplained weight loss include malignancy, gastrointestinal diseases, endocrine disorders, and psychiatric conditions. Malignancies, particularly of the lung, pancreas, and gastrointestinal tract, are the most common serious causes. Malabsorption syndromes, peptic ulcer disease, and inflammatory bowel disease are among the gastrointestinal causes. Endocrine disorders, such as hyperthyroidism and diabetes mellitus, can also lead to weight loss. Depression and other psychiatric disorders are often overlooked causes.
After the initial evaluation, laboratory tests and imaging studies should be guided by the clinical suspicion. Basic tests include complete blood count, metabolic panel, thyroid function tests, and urinalysis. Depending on the patient's history and physical examination, further investigations may include endoscopy, computed tomography, or psychiatric evaluation.
Treatment should be directed at the underlying cause. In many cases, this may involve a multidisciplinary approach involving oncologists, gastroenterologists, endocrinologists, and psychiatrists. Regular follow-up is essential to monitor the patient's response to treatment and to detect any new symptoms or signs.
Unexplained weight loss is a challenging clinical problem that requires a thorough and systematic approach. By understanding the common causes and adopting a comprehensive diagnostic strategy, physicians can effectively manage these patients and improve their outcomes.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation